| Financial Year |
March 31 2023 |
| Monetary Funds |
177,515,568.90 |
| Held-for-trading Financial Assets |
968,978,764.22 |
| Notes Receivable |
-- |
| Accounts Receivable |
143,521,268.95 |
| Advances to Suppliers |
227,528,490.82 |
| Other Receivables |
9,058,340.14 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
232,608,763.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,152,813.58 |
| Total Current Assets |
1,763,364,009.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
177,091,753.04 |
| Investment Properties |
-- |
| Fixed Assetes |
168,607,724.75 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
54,340,654.80 |
| R&D expenses |
-- |
| Goodwill |
8,786,066.29 |
| Long-Term Deferred and Prepaid Expenses |
2,870,390.56 |
| Deferred Income Tax Assets |
18,360,953.44 |
| Other Non-Current Assets |
56,113.07 |
| Sub-Total of Non-Current Assets |
460,199,669.41 |
| Total Assets |
2,223,563,679.24 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
99,265,897.92 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,609,007.61 |
| Taxes Payable |
14,900,265.15 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,847,039.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,852,421.86 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
155,725,710.09 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,726,558.71 |
| Total Liabilities |
178,452,268.80 |
| Paid-In Capital(Or Share Stock) |
162,503,585.00 |
| Capital Surplus |
982,196,545.91 |
| Surplus Reserve |
81,251,792.50 |
| LESS:Treasury Stock |
160,420,820.73 |
| Undistributed Profits |
960,947,759.24 |
| Minority Stockholder's Interest |
28,281,833.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,016,829,576.96 |
| Owner's Equity（Stockholder's Equity） |
2,045,111,410.44 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,223,563,679.24 |
